# Eagle Eye Solutions Group plc

Parent company financial statements
Registered number 8892109
30 April 2025
Prepared for the purpose of s838
Companies Act 2006

FRIDAY
*AE71TSDV*
A20 18/07/2025 #59
COMPANIES HOUSE

---

# Essile Eye Solutions Group plc

Parent company financial statements
R&amp;D 30 April 2023
30 April 2023
Prepared for the purpose of 2023

---

# Company statement of profit or loss and total comprehensive income for the 10 month period ended 30 April 2025

|   | Note | 30 April 2025  |
| --- | --- | --- |
|   |   |  £000  |
|  Income from shares in Group undertakings | 2 | 7,403  |
|  Operating expenses |  | (563)  |
|  Profit before taxation |  | 6,840  |
|  Taxation |  | -  |
|  Profit after taxation for the period |  | 6,840  |

---

# Company statement of financial position
as at 30 April 2025

|   | 30 April 2025 £000  |
| --- | --- |
|  Non-current assets |   |
|  Investments in subsidiaries | 30,814  |
|  Current assets |   |
|  Trade and other receivables | 10,694  |
|  Cash and cash equivalents | 21  |
|   | 10,715  |
|  Total assets | 41,529  |
|  Current liabilities |   |
|  Trade and other payables | (200)  |
|  Total liabilities | (200)  |
|  Net assets | 41,329  |
|  Equity attributable to owners of the parent |   |
|  Share capital | 297  |
|  Share premium | 30,110  |
|  Share option reserve | 9,496  |
|  Retained earnings | 1,426  |
|  Total equity | 41,329  |

These financial statements were approved by the Board on 9 June 2025 and signed on its behalf by

L. Sharman-Munday
Director

T. Mason
Director

Company number 08892109

---

# Company statement of changes in equity for the 10 month period ended 30 April 2025

|   | Share capital £000 | Share premium £000 | Share option reserve £000 | Retained earnings/ (losses) £000 | Total £000  |
| --- | --- | --- | --- | --- | --- |
|  Balance at 1 July 2024 | 296 | 30,089 | 9,084 | (5,594) | 33,875  |
|  Profit for the financial period
| - | - | - |
6,840 | 6,840  |
|  Transactions with owners recognised in equity |  |  |  |  |   |
|  Exercise of share options | 1 | 21
| - | - |
22  |
|  Fair value of share options exercised in the period
| - | - |
(180) | 180 | -  |
|  Share-based payment charge
| - | - |
592 | - | 592  |
|   | 1 | 21 | 412 | 180 | 614  |
|  Balance at 30 April 2025 | 297 | 30,110 | 9,496 | 1,426 | 41,329  |

---

# Notes to the company financial statements

## 1 Basis of preparation

Eagle Eye Solutions Group plc is a public limited company incorporated and domiciled in the United Kingdom under the Companies Act 2006 (Registration number 08892109). The address of the registered office is 5 New Street Square, London, EC4A 3TW.

The Company received shareholder approval at the Annual General Meeting on 21 November 2024 to make market purchases of its own shares. These interim financial statements have been prepared under sections 836 and 838 of the Companies Act 2006 (the Act) for the purposes of confirming that the Company has sufficient distributable reserves to make such market purchases.

These financial statements contain information about Eagle Eye Solutions Group plc solely as an individual company. The statements have been prepared on the basis of the same recognition and measurement principles as adopted by the Company in preparing the Company's financial statements included within the Eagle Eye Solutions Group plc annual report for the year ended 30 June 2024. The interim accounts have been properly prepared in accordance with s838 of the Act, subject only to those departures, under s838(3), which the Directors have considered are not material for determining whether the proposed distribution is permitted by s830 and s831 of the Act. The Directors have chosen not to present comparative figures for the period and the note disclosures that would normally form part of a set of complete financial statements.

## 2 Retained earnings

The Company's profits being used for this distribution arose from the receipt, since 30 June 2024, of £7 4m of dividends from various Group subsidiaries arising from trading profits made by those entities. Following receipt of these dividends, as at 30 April 2025, the Company has retained earnings of £1 4m, all of which represent realised profits available for distribution.

---

1

# 1 Basis of preparation

Table 1: The Company financial statements

Table 2: The Company's financial statements

The Company received shareholder approval of the Annual General Meeting on 31 November 2024 to make market purchases of its own shares. These internal financial statements have been prepared under sections 837 and 838 of the Companies Act 2008 (the Act) for the purposes of confirming that the Company has sufficient distribution reserves to make such market purchases.

These financial statements contain information about Eagle Eye Solutions Group Inc. solely as an individual company. The statements have been prepared on the basis of the same recognition and measurement principles as adopted by the Company in preparing the Company's financial statements included within the Eagle Eye and the Blue Eye. The Company's financial statements were properly prepared in accordance with 2828 of the Act, subject only to those described, under 2828(2), which the Director have considered are not material for determining whether the proposed distribution is permitted by 2830 and 2831 of the Act. The Directors have chosen not to present comparative figures for the period and the note disclosures that would normally form part of a act of complete financial statements.

## 2 Retained earnings

The Company's profit being used for this distribution arose from the receipt since 30 June 2024, of £74m of dividends from various Group subsidiaries arising from trading profits made by those entities. Following receipt of these dividends, as of 30 April 2025, the Company has retained earnings of £1.4m, or of which represent realized profits available for distribution.